ClinicalTrialsFinder

ER Positive Breast Cancer Clinical Trials in Porto Alegre, Rio Grande do Sul

1 recruitingPorto Alegre, Rio Grande do Sul, Brazil

Showing 1–1 of 1 trials

Recruiting
Phase 3

OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer

Breast CancerMetastatic Breast CancerAdvanced Breast Cancer+1 more
Olema Pharmaceuticals, Inc.510 enrolled233 locationsNCT06016738